Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices 63969 

CONTACT PERSON FOR MORE INFORMATION: 

Melissa D. Jurgens, 202–418–5516. 

Natise Stowe, 

Executive Assistant. 

[FR Doc. 2013–25268 Filed 10–23–13; 11:15 am] 

BILLING CODE 6351–01–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Sunshine Act Meeting Notice 

TIME AND DATE: Wednesday, October 30, 

2013, 10 a.m.–12 p.m. 

PLACE: Room 420, Bethesda Towers, 

4330 East West Highway, Bethesda, 

Maryland. 

STATUS: Commission Meeting—Open to 

the Public. 

Matters To Be Considered 

Briefing: FY 2014 Operating Plan. 

A live Web cast of the meeting can be 

viewed at www.cpsc.gov/live. For a 

recorded message containing the latest 

agenda information, call (301) 504– 

7948. 

Contact Person For More Information: 

Todd A. Stevenson, Office of the 

Secretary, U.S. Consumer Product 

Safety Commission, 4330 East West 

Highway, Bethesda, MD 20814, (301) 

504–7923. 

Dated: October 23, 2013. 

Todd A. Stevenson, 

Secretary. 

[FR Doc. 2013–25387 Filed 10–23–13; 4:15 pm] 

BILLING CODE 6355–01–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Defense Health Board; Notice of 

Federal Advisory Committee Meeting 

AGENCY: Department of Defense (DoD). 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The Department of Defense is 

publishing this notice to announce that 

the following Federal Advisory 

Committee meeting of the Defense 

Health Board will take place. 

DATES: 

Monday, November 18, 2013 

8:00 a.m.–8:45 a.m. (Administrative 

Working Meeting) 

9:00 a.m.–12:00 p.m. (Open Session) 

12:00 p.m.–1:00 p.m. (Administrative 

Working Meeting) 

1:00 p.m.–5:30 p.m. (Open Session) 

Tuesday, November 19, 2013 

7:15 a.m.–1:30 p.m. (Administrative 

Working Meeting) 

ADDRESSES: Defense Health 

Headquarters (DHHQ), Pavilion Salons 

B–C, 7700 Arlington Blvd., Falls 

Church, Virginia 22042 (escort required; 

see guidance in SUPPLEMENTARY

INFORMATION, ‘‘Public’s Accessibility to 

the Meeting.’’) 

FOR FURTHER INFORMATION CONTACT: The 

Director of the Defense Health Board is 

Ms. Christine Bader, 7700 Arlington 

Boulevard, Suite 5101, Falls Church, 

Virginia 22042, (703) 681–6653, Fax: 

(703) 681–9539, Christine.bader@

dha.mil. For meeting information, 

please contact Ms. Kendal Brown, 7700 

Arlington Boulevard, Suite 5101, Falls 

Church, Virginia 22042, 

Kendal.Brown.ctr@dha.mil, (703) 681– 

6670, Fax: (703) 681–9539. 

SUPPLEMENTARY INFORMATION: This 

meeting is being held under the 

provisions of the Federal Advisory 

Committee Act of 1972 (5 U.S.C., 

Appendix, as amended), the 

Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended), and 

41 CFR 102–3.150, and in accordance 

with section 10(a)(2) of Public Law. 

Additional information, including the 

agenda and electronic registration, is 

available at the DHB Web site, http://

www.health.mil/dhb/meeting-2013-11- 

1819.cfm. 

Purpose of the Meeting: The purpose 

of the meeting is to address and 

deliberate pending and new issues 

before the Board. 

Agenda: Pursuant to 5 U.S.C. 552b, as 

amended, and 41 CFR 102–3.140 

through 102–3.165 and subject to 

availability of space, the DHB meeting is 

open to the public from 9:00 a.m. to 

12:00 p.m. and 1:00 p.m. to 5:30 p.m. on 

November 18, 2013. On November 18, 

2013, the DHB will receive briefings 

from the Department to include 

concussive care in theater, DoD’s 

suicide prevention efforts, DoD 

Pharmaceutical Operations, and the 

Millennium Cohort Study with an 

overview of its findings. The Board will 

vote on proposed recommendations 

regarding the trends in overweight and 

obesity in America for the DoD. 

Additionally, the Board will receive 

briefings on the progress being made by 

the subcommittees on dual loyalties of 

military medical providers, the 

sustainment and advancement of 

amputee care, deployment pulmonary 

health, theater trauma lessons learned 

and Continuing Health Education. 

Public’s Accessibility to the Meeting: 

Pursuant to 5 U.S.C. 552b, as amended, 

and 41 CFR 102–3.140 through 102– 

3.165 and subject to availability of 

space, this meeting is open to the 

public. Seating is limited and is on a 

first-come basis. All members of the 

public who wish to attend the public 

meeting must contact Ms. Kendal Brown 

at the number listed in the section FOR

FURTHER INFORMATION CONTACT no later 

than noon on Friday, November 8 to 

register and make arrangements for a 

DHHQ escort, if necessary. Public 

attendees requiring escort should arrive 

at the DHHQ Visitor’s Entrance with 

sufficient time to complete security 

screening no later than 8:30 a.m. on 

November 18. To complete security 

screening, please come prepared to 

present two forms of identification and 

one must be a picture identification 

card. 

Special Accommodations: Individuals 

requiring special accommodations to 

access the public meeting should 

contact Ms. Kendal Brown at least five 

(5) business days prior to the meeting so 

that appropriate arrangements can be 

made. 

Written Statements: Any member of 

the public wishing to provide comments 

to the DHB may do so in accordance 

with 41 CFR 102–3.105(j) and 102–3.140 

and section 10(a)(3) of the Federal 

Advisory Committee Act, and the 

procedures described in this notice. 

Individuals desiring to provide 

comments to the DHB may do so by 

submitting a written statement to the 

DHB Designated Federal Officer (DFO) 

(see FOR FURTHER INFORMATION CONTACT). 

Written statements should address the 

following details: the issue, discussion, 

and a recommended course of action. 

Supporting documentation may also be 

included, as needed, to establish the 

appropriate historical context and to 

provide any necessary background 

information. 

If the written statement is not 

received at least five (5) business days 

prior to the meeting, the DFO may 

choose to postpone consideration of the 

statement until the next open meeting. 

The DFO will review all timely 

submissions with the DHB President 

and ensure they are provided to 

members of the DHB before the meeting 

that is subject to this notice. After 

reviewing the written comments, the 

President and the DFO may choose to 

invite the submitter to orally present 

their issue during an open portion of 

this meeting or at a future meeting. The 

DFO, in consultation with the DHB 

President, may allot time for members of 

the public to present their issues for 

review and discussion by the Defense 

Health Board. 


emcdonald on DSK67QTVN1PROD with NOTICES